Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02489526 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery
A Phase 2 study, sponsored by Vivozon.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02489526 is a Phase 2 study that has completed, run by Vivozon. The registered enrollment target is 60 participants.
The verdict
NCT02489526, a Phase 2 study, has completed, sponsored by Vivozon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this Phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.
Interventions
- DRUG Placebo
- DRUG VVZ-149 Injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-09-28 |
| Est. Completion | 2016-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02489526
The ClinicalTrials.gov registry entry for NCT02489526 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivozon, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02489526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02489526 about?
NCT02489526 is a clinical study titled "Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery". The purpose of this Phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.
What is the current status of trial NCT02489526?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2015-09-28. Estimated completion is 2016-08-15.
What interventions are being tested in trial NCT02489526?
The interventions under investigation include: Placebo (DRUG), VVZ-149 Injections (DRUG).
Who is sponsoring clinical trial NCT02489526?
This trial is sponsored by Vivozon, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.